…
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterra and White Cloud. brand names, as well as under private labels. It sells its products through the retail channels, such as grocery stores, mass merchandisers, club stores, drug stores, and convenience stores; and distributors to businesses involved in property management, health care, food service, manufacturing and lodging, education, and lodging. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
KP Tissue Inc is a Canadian maker and distributor of household tissue and related paper products for retail and commercial customers. Long-term growth drivers include stable consumer demand, operational-efficiency gains and scale from private-label and contract relationships. The company may appeal to investors seeking defensive exposure and relatively predictable cash flows within consumer staples.
Key risks are volatile pulp and energy input costs, intense competition from larger and private-label producers, and sensitivity to leverage and cost-pass-through that could pressure margins.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 8.50M | 2.49M | 1.03M | -12.55M | 1.12M |
| Net income | 8.50M | 2.43M | -4.94M | -10.25M | 1.24M |
| Ebit | - | 0.00M | 0.00M | -116.74M | -153.75M |
| Ebitda | - | 264.78M | 238.61M | -0.75M | -0.32M |
| Depreciation and amortization | - | 264.78M | 238.61M | 115.99M | 153.43M |
| Operating income | 0.00M | 0.00M | -1.86M | -12.55M | -0.32M |
| Other operating expenses | - | - | 0.83M | 12.55M | 0.32M |
| Interest expense | - | - | - | - | 0.00M |
| Tax provision | 0.00M | 0.06M | 4.11M | -2.30M | -0.12M |
| Interest income | 8.50M | 2.49M | - | 12.55M | 1.12M |
| Income tax expense | - | 0.06M | 4.11M | -2.30M | -0.12M |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | - | - | 0.83M | -12.55M | -0.32M |
| Total other income expense net | - | 2.49M | 1.03M | 0.75M | 1.44M |
| Net income from continuing ops | 8.50M | 2.43M | -4.94M | -10.25M | 1.24M |
| Net income applicable to common shares | 8.50M | 2.43M | - | -10.25M | 1.24M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 71.60M | 71.31M | 70.61M | 81.71M | 80.72M |
| Other current assets | - | - | 0.00M | 2.37M | 1.99M |
| Total liab | 1.80M | 1.80M | 2.25M | 7.68M | 4.85M |
| Total stockholder equity | 69.80M | 69.52M | 68.36M | 74.03M | 75.87M |
| Other current liab | 1.80M | - | 2.25M | 1.96M | 4.04M |
| Common stock | 23.00M | - | 22.56M | 22.38M | 21.84M |
| Capital stock | 23.00M | 22.76M | 22.56M | 22.38M | 21.84M |
| Retained earnings | -114.98M | -116.67M | -115.03M | -108.01M | -103.56M |
| Other liab | - | - | - | 5.72M | 0.81M |
| Total current liabilities | 1.80M | 1.80M | 2.25M | 1.96M | 4.04M |
| Short term debt | 0.00M | - | - | 0.00M | 0.00M |
| Other stockholder equity | 144.82M | - | 144.82M | 159.66M | 157.59M |
| Total current assets | 1.80M | 1.80M | 2.44M | 2.37M | 1.99M |
| Net tangible assets | - | - | - | 74.03M | 75.87M |
| Net receivables | 1.80M | - | 2.44M | 1.79M | 1.99M |
| Accumulated other comprehensive income | 16.96M | - | 16.00M | - | - |
| Non currrent assets other | - | - | - | 79.34M | 78.73M |
| Non current assets total | 69.80M | 69.52M | 68.16M | 79.34M | 78.73M |
| Long term debt total | 0.00M | - | - | 0.00M | 0.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 6.97M | 6.98M | 6.62M | 5.56M |
| Change to liabilities | - | - | - | -0.08M | 0.21M |
| Total cashflows from investing activities | 6.96M | 6.97M | - | 6.62M | 5.56M |
| Total cash from financing activities | -6.96M | -6.97M | -6.98M | -6.62M | -5.56M |
| Net income | 8.50M | 2.43M | -4.94M | -10.25M | 1.24M |
| Change in cash | 0.00M | 0.00M | 6.98M | 6.62M | 1.15M |
| Begin period cash flow | 0.00M | 6.98M | 6.62M | 1.15M | 0.00M |
| End period cash flow | 0.00M | 0.00M | 6.98M | 6.62M | 1.15M |
| Total cash from operating activities | 0.00M | 0.00M | 6.98M | 6.62M | 1.15M |
| Other cashflows from investing activities | 6.96M | 6.97M | - | 6.62M | 5.56M |
| Dividends paid | 6.96M | -6.97M | 6.98M | 6.62M | 5.56M |
| Change to account receivables | - | - | - | - | 2.07M |
| Other cashflows from financing activities | - | - | 6.98M | 6.62M | 5.56M |
| Change to netincome | - | - | - | 10.32M | -1.47M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.00M | -0.59M | 0.29M | -0.08M | 0.23M |
| Other non cash items | -0.43M | -1.84M | 7.53M | 18.83M | 1.89M |
| Free cash flow | 0.00M | 0.00M | 6.98M | 6.62M | 1.15M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| KPT KP Tissue Inc |
- -% |
11.97 | 13.08 | 15.20 | - | 1.59 |
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterra and White Cloud. brand names, as well as under private labels. It sells its products through the retail channels, such as grocery stores, mass merchandisers, club stores, drug stores, and convenience stores; and distributors to businesses involved in property management, health care, food service, manufacturing and lodging, education, and lodging. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Dino J. Bianco | Chief Exec. Officer | 1962 |
| Mr. Mark Holbrook | Chief Financial Officer | NA |
| Mr. Michel Manseau | Sr. VP & GM of Consumer Bus. Canada - Kruger Products LP | NA |
| Mr. Gordon Goss | Sr. VP and GM of Consumer Bus. USA & Mexico - Kruger Products LP | NA |
| Mr. Marc James Fitzgerald | Corp. VP of Technology & Product Devel. - Kruger Products LP | NA |
| Mike Baldesarra CPA, CA | Director of Investor Relations | NA |
| Mr. François Paroyan | SVP of Gen. Counsel & Corp. Affairs and Corp. Sec. | NA |
| Mr. Rob Latter | Sr. VP & GM of Away from Home Bus. - Kruger Products LP | NA |
| Ms. Nancy Marcus | Chief Marketing Officer of Kruger Products LP | NA |
| Ms. Susan Irving | Chief Marketing Officer of KPLP | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.